You are here: Industry Insights > Moderna

News List

Third COVID-19 vaccine dose could improve protection in transplant recipients europeanpharmaceuticalreview
August 13, 2021
The results from the first COVID-19 vaccine booster trial in transplant recipients show a third dose is safe and highly immunogenic.
Moderna Vaccine May Shield More Against Breakthrough Infections Than Pfizer: Study drugs
August 13, 2021
People fully vaccinated with the Moderna COVID-19 vaccine appear to have a lower risk for a "breakthrough" infection caused by the delta variant than those who received the Pfizer vaccine, a new, preliminary report suggests.
Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months firstwordpharma
August 13, 2021
Moderna, Inc. (Nasdaq:MRNA), today announced the publication of new data on the durability of the Moderna COVID-19 vaccine in generating neutralizing antibodies against vaccine in generating neutralizing antibodies against variants of concern.
Moderna to build mRNA vaccine manufacturing facility in Canada cphi-online
August 12, 2021
The new facility will provide access to domestically manufactured vaccines against respiratory viruses
Antibody levels predictive of Moderna’s vaccine efficacy, says study expresspharma
August 12, 2021
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high levels of antibodies.
Moderna records $4.4bn total revenue in Q2 2021 pharmaceutical-technology
August 09, 2021
Moderna has reported total revenue of $4.4bn in the second quarter (Q2) of the fiscal year (FY) 2021, a surge from $67m in the same quarter last year.
Japan studying giving third COVID-19 shots next year firstwordpharma
August 09, 2021
Japan has begun a study on whether it should administer third doses of COVID-19 vaccines next year, as reported The Japan Times.
Gov’t launches study on COVID-19 vaccine dose interval for pregnant women pharmatimes
August 06, 2021
A new clinical trial investigating the optimal gap between first and second COVID-19 vaccine doses for pregnant women is set to launch in England 3rd.
Moderna Vaccine's Protection Does Not Wane After Six Months: Report drugs
August 06, 2021
Moderna Inc. announced on Thursday that the potency of its vaccine does not dim in the first six months after the second dose.
Combination of the first component of Sputnik V vaccine (Sputnik Light vaccine) with vaccines by AstraZeneca, Sinopharm and Moderna demonstrates high safety profile during the study in Argentina’s Bue firstwordpharma
August 05, 2021
RDIF announces the initial safety results of the randomized, single-blind study for the evaluation of the immune response and safety of heterogeneous regimens combining the first component of the Russian Sputnik V vaccine against coronavirus.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page